MedPath

Safety and Efficacy Study of MRE0094 to Treat Chronic, Neuropathic, Diabetic Foot Ulcers

Phase 2
Completed
Conditions
Foot Ulcer, Diabetic
Diabetes Complications
Registration Number
NCT00312364
Lead Sponsor
Pfizer
Brief Summary

This is a clinical research study of an experimental topical drug for the treatment of chronic, neuropathic, diabetic foot ulcers.

Patients participating in the study may receive an active drug (MRE0094), inactive drug (placebo), or a gel used to treat diabetic foot ulcers currently available for sale in the United States. What treatment a patient will receive is determined by chance (like drawing a number from a hat). All patients will receive additional care for diabetic foot ulcers during the study.

Participation in the study can be up to 4½ months.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
322
Inclusion Criteria

Participants included in the study must:

  • Have type 1 or type 2 diabetes mellitus.
  • Have problems with the nerves in their feet.
  • Have an ulcer on the bottom surface of their foot that has been present for 3 weeks or more and is of sufficient size to qualify for the study.
  • Be able to apply study drug to their ulcer, or have a caregiver do it.
  • Be able to visit the doctor regularly during the 4½ month study.
Exclusion Criteria

Participants may not participate in the study if:

  • Their ulcer is caused by bad blood flow to their foot.
  • Their ulcer is infected.
  • They cannot wear a special boot during the study to take pressure off the ulcer.
  • They have certain other diseases, or are using certain types of drugs.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Incidence of complete healing of target ulcer at endpoint or 90 days, whichever is earlier.
Secondary Outcome Measures
NameTimeMethod
Time to closure and percent reduction in surface area of the target ulcer.
Incidence, intensity, and seriousness of adverse events. Changes in irritation scores.

Trial Locations

Locations (63)

Institute for Advanced Wound Care

🇺🇸

Montgomery, Alabama, United States

Palo Verde Foot and Ankle

🇺🇸

Bullhead City, Arizona, United States

Carl T. Hayden VA Medical Center

🇺🇸

Phoenix, Arizona, United States

Associated Foot & Ankle Specialists, LLC

🇺🇸

Phoenix, Arizona, United States

Aung Foot Health Clinics & Advanced Wound Care

🇺🇸

Tucson, Arizona, United States

Southern Arizona VA Health Care System

🇺🇸

Tucson, Arizona, United States

Vertex Clinical Research

🇺🇸

Bakersfield, California, United States

Roy O. Kroeker, DPM

🇺🇸

Fresno, California, United States

Innovative Medical Technologies

🇺🇸

Los Angeles, California, United States

UCSD Wound Treatment and Research Center

🇺🇸

San Diego, California, United States

Scroll for more (53 remaining)
Institute for Advanced Wound Care
🇺🇸Montgomery, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.